English | Español
Robert Hadley | Jun 11, 2017

GlaxoSmithKline submits single-tablet, dual-drug HIV regimen for FDA approval
Ruth de Jauregui | Jun 10, 2017

Bristol-Myers Squibb says Phase II of Sprycel in pediatric chronic myeloid leukemia cases shows promise
Ruth de Jauregui | Jun 10, 2017

Amgen says Xgeva trial shows promise as option for patients with multiple myeloma
Ruth de Jauregui | Jun 10, 2017

American Cancer Society points out health care barriers the LGBT community faces
Ruth de Jauregui | Jun 8, 2017

BioMarin's Brineura gets European approval for treating CLN2 brain disease in children
Ruth de Jauregui | Jun 8, 2017

Anthem leaving Ohio health insurance exchange
Ruth de Jauregui | Jun 8, 2017

American Heart Association reports arteries can stay healthy into 70s and beyond
Michael McGrady | Jun 8, 2017

American Medical Association applauds Anthem-Cigna merger rejection

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’